2020-06-30T12:16:40-07:00 2019-08-31 990 2018-09-01 581698648 THE TASK FORCE FOR GLOBAL HEALTH INC TASK 4045921430 325 Swanton Way Decatur GA 300303001 William Nichols Chief Operating Officer 4045921430 2020-03-02 99.52.255.189 2018 2020-09-23 17:36:50Z William Nichols 325 Swanton Way Decatur GA 30030 56376601 0 X www.taskforce.org X 1986 GA The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery. 11 10 175 4 0 0 45383048 54141049 0 0 201199 845317 -322185 -54150 45262062 54932216 5399935 2625131 0 0 18013111 19120319 0 0 221874 38360394 30111646 61773440 51857096 -16511378 3075120 61988899 66280703 11537951 12754635 50450948 53526068 The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery. 0 0 18909977 0 21865785 The Health Systems Strengthening sector includes Public Health Informatics Institute(PHII); Training Programs in Epidemiology and Public Health(TEPHINET); African Health Workforce Project(AWP) and MedSurplus Alliance(MSA). PHII provided direct services to the U.S. public health system through a cooperative agreement with the Centers for Disease Control (CDC), and funding from the Robert Wood Johnson foundation. This funding supported PHII and its partners in efforts to increase the capacity of public health informaticians and other public health leaders and practitioners to improve the collection, management and use of information and information technology for protecting and improving health and reducing disparities. Key activities included providing technical assistance and online tools to state and local health departments in linking to private healthcare electronic records systems for the purpose of electronically reporting disease cases; providing training to public health professionals in essential informatics competencies; and assessing non-communicable and injury epidemiology capacity in state and/or local health departments in informatics, data and methods. Additionally, PHII is a partner on a collaborative Gates Foundation-funded project that is collecting data to reduce childhood mortality across the globe; this project is working on mortality surveillance activities at sites in Asia and Sub Saharan Africa. Finally, this year, Emory's Department of Human Genetics and the Metabolic Nutrition Program continued to fund PHII in designing and building a health information system that streamlines multiple sources of information about patients with metabolic disorders. The new system will enable providers to manage their patients' overall healthcare needs in a more efficient manner, including specialized food and formulas prescribed for patients. TEPHINET met with global health leaders, including WHO Director-General, to begin operationalizing the recommendations made in the Global Field Epidemiology Roadmap. Hosted the 10th TEPHINET Global Scientific Conference, convening approximately 600 field epidemiologists and other public health professionals from more than 80 countries and officially launched the FETP Enterprise and announced the formation of a strategic leadership group to drive its progress. The Program formed the FETP Learning Advisory Council and began developing a comprehensive new learning strategy for the FETP Enterprise in order to ensure a well-trained and professional global field epidemiology workforce prepared to address evolving public health priorities. It accredited four FETPs, opened the fifth cycle of FETP accreditation and formed the TEPHINET Advisory Scientific Committee to provide strategic, science-based recommendations to the TEPHINET Secretariat. In addition, it collaborated with the Focus Area for Compassion and Ethics on a survey to better understand ethical dilemmas encountered by professional field epidemiologists and developed training modules on practical ethics for veterinarians and global health photography ethics. It also held a training on Epidemiology in Humanitarian Emergencies in Uganda for FETP graduates in partnership with AFENET, WHO and CDC and organized the 2019 FETP International Nights at the 68th Annual EIS Conference. Awarded 20 small grants to FETP fellows and graduates working on projects related to non-communicable diseases and cancer and collaborated with ministries of health and higher education to increase biosafety and biosecurity standards in Iraq and Yemen. Received funding from and collaborated with CDC, U.S. Department of State, CDC Foundation, and CRDF Global to implement approximately 40 public health projects related to maternal and child health, infection prevention and control, non-communicable diseases, influenza surveillance, biosafety and biosecurity, polio eradication, operational support to FETPs, and more. AWP is winding up its activities and will end on May 31, 2020. During this past year, the team worked with the University of Nairobi to create an online certificate course in Data Management, Analysis, and Dissemination, with 3 learning modules to teach participants the FUNDAMENTALS OF HUMAN RESOURCES FOR HEALTH DATA MANAGEMENT (module #1), BASIC STATISTICAL CONCEPTS AND APPROACHES FOR HRH DATA USE (module #2), and HRH INFORMATION DISSEMINATION (module #3). This course will be offered online, initially free of charge, to all health managers and human resource managers in Kenya. In collaboration with the National AIDS and STI Control Program (NASCOP), the Project developed a human resource information system to track all professionals who have trained in HIV counseling and testing and certified by NASCOP. It also established electronic interoperability between the regulatory human resource information system and the Ministry of Health human resource information system so that data is now easily available on all healthcare providers hired by the government health system. This allows HR managers to easily determine which professionals have an up-to-date license and practicing legally and which are not, improving the quality of health care. MSA Program - The MedSurplus Alliance Code of Conduct, Accreditation Program, stakeholder programs and education resources are helping to build responsible medical product donation programs through donor education, donation program certification, and cross-sector collaborations. MSA-accredited medical surplus recovery organization (MSRO) partnered with Ministries of Health in West and Sub-Saharan Africa, Central America, the Caribbean, and Asia to align product donations with local health system strengthening programs and goals. There were some cross-sector medical product donation programs (i)Ascension Global Mission / Ascension Health Product Donation: Participating hospitals donated medical consumables, durable goods and equipment valued at $1,522,628.43 to support 600 shipments to clinical care locations the Americas, Caribbean, Africa and Asia. (ii) Kits4Life: The MSA serves as the secretariat for the Kits4Life Advisory Council and manages the Kits4Life donation program pilot. The Council advises, assists, supports and advocates for the Kits4Life program on matters that will strengthen access and the repurpose of surplus medical supplies for humanitarian aid opportunities for clients served by Medical Surplus Alliance and its affiliated MSROs. Under Education and Capacity Building, it held The Joint Global Summit: Compassion, Ethics, and Excellence in Global Health and Short-Term Medical Missions Symposium. The MSA and Catholic Health Association co-hosted a two-day event meeting of 100 professionals, academics, and students from around the world to explore what happens when core values collide with operational imperatives, cultural bias, and ethical blind spots. 18737532 990828 17194930 The Neglected Tropical Disease sector includes: CWW (Children Without Worms); ITI (The International Trachoma Initiative); NTD-SC (the Neglected Tropical Disease-Support Center); MDP (The Mectizan Donation Program) and GPZL (Global Partnership for Zero Leprosy). Funded principally by the Bill & Melinda Gates Foundation, the U.S. Agency for International Development and the Department for International Development (UK AID), the NTD-SC aims to optimize Operational Research (OR) to eliminate neglected tropical diseases which threaten the lives and well-being of more than one billion of people in some of the world's poorest communities. As of 2019, the NTD-SC manages a portfolio of more than 200 OR projects spanning 60 countries and targeting all five neglected tropical diseases amenable to preventive chemotherapy: lymphatic filariasis, onchocerciasis, STH, schistosomiasis and trachoma, morbidity and social science. Some of these OR study products have resulted into program recommendations which the World Health Organization (WHO) has endorsed and adopted into WHO policy while others are clinical trials which may result in new therapies for NTD diseases. In addition, the NTD-SC serves as the Secretariat for the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) yearly meeting. This meeting brings together a growing group of researchers and country program implementers working to foster important collaborations to address the challenges faced by NTD programs which prevent the shared goal of eliminating these infections. The 2-day event convened four hundred fifty individuals from more than 40 countries and 128 different organizations for 24 breakout sessions, translating ideas into future OR projects for 2020. In addition, the NTD-SC is working with African Research Network for NTDs (ARNTD) support a small grants program sponsored by USAID and UK AID, to develop research capacity in the African region. At the 2018 COR-NTD meeting, 18 young investigators were provided support to conduct their studies in 2019. CWW During the reporting period, CWW continued the management of the GSK-supported NTDeliver supply chain web-based information portal. National Ministries of Health, the World Health Organization (WHO), pharmaceutical, and implementing partners use the online database to track requests for donated medicines used in the control and elimination of various neglected tropical diseases (NTDs). From September 1, 2018 to August 31, 2019, CWW supported the accurate and timely delivery and monitoring of 97 consignments of GSK Albendazole to 55 countries for lymphatic filariasis & STH. The total delivered treatments were 967,907,000. In FY19, CWW continued to support the Bangladesh national STH program in its efforts to map the post-intervention STH burden and conduct community-level surveys in four additional districts including a rural versus urban risk area comparison in Dhaka district. Data from seven districts was concatenated and analyzed together with significant outcomes that are informing further program decisions: this analysis was presented at ASTMH by CWW in November 2019. A protocol and checklist were also developed for investigating areas of continued high transmission ("hot spots") in two surveyed districts. The fieldwork is ongoing, and led by the CWW Technical Advisor in Dhaka. CWW efforts to support and position the STH Advisory Committee as the recognized global technical body for STH-related issues led to the 2018 annual STH Advisory Committee meeting being held jointly with the WHO to propose targets for STH control post-2020. This was the first time that WHO formally requested a joint Consultation with the CWW-assisted STH Advisory Committee, and shows the significant progress in bridging this relationship as a result of CWW and partners' efforts. The meeting brought together 37 independent experts drawn from 19 organizations as well as WHO participants from Geneva, regional, and country offices. In Kenya, we finalized a formal agreement with the Kenyan Red Cross Society/NTD Program and the African Field Epidemiology Network/FELTP to initiate the sustainable M&E implementation in Kenya. Through this engagement, we are supporting a full-time FELTP resident who is seconded to the NTD program for two years to facilitate the data management and M&E capacity-strengthening project. ITI works tirelessly for a world free from trachoma. ITI provides stewardship for Pfizer's donation of Zithromax(R) to treat and prevent trachoma; builds and strengthens partnerships to accelerate progress; and develops innovative tools and methods to share data. In 2019, ITI published the Zithromax(R) Management Guide with the goal of enhancing safety, ease, and acceptability of Zithromax(R) administration. The Guide is designed for all stakeholders at all levels who use donated Zithromax(R) for trachoma elimination. Between September 2018 to August 2019, ITI also organized just-in-time shipments of 110,128,992 treatments for trachoma shipped to be distributed at mass drug administrations in 20 countries. As of August 2019, ITI has shipped more than 876,014,787 million treatments to trachoma endemic countries since 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision making on where antibiotic treatments are needed and where they can be stopped. In partnership with the Royal Society for Tropical Medicine and Hygiene (RSTMH), ITI supported trachoma research for four selected small grants of up to £5,000. ITI's commitment to strong stewardship of the antibiotic donation from Pfizer, coupled with its solid data management and transparent communications, have contributed to remarkable achievements by the global trachoma community in reducing the population at risk of blindness from this preventable disease from an estimated 1.2 billion people in 2000 to 142 million in 2018. ITI will continue to enhance its support, improve its effectiveness, and increase its efficiencies to maximize impact. GPZL Program's GPZL Research Agenda was published in Leprosy review and a commentary is underway for The Lancet Infectious Diseases. This effort included more than 160 researchers from 25+ countries. A National Zero Leprosy model (national peer-to-peer assessment tool and visioning template) was developed with a working group of over 140 participants. It was tested in Nepal (July) and Morocco (October). An online the Zero Leprosy Toolkit and Helpdesk for Country Capacity Building were developed. Work continued to foster a community of practice and innovation by developing tools and sharing best practices and opportunities, including during the 2019 Global Leprosy Congress, the NNN and COR-NTD meetings and at WHO regional meetings. Workshops and sessions took place at the ILC and NNN meetings. A session was organized for the AFRO regional meeting with 4 GPZL Leadership Team members participating. Policy guidance was compiled and shared for the WHO leprosy 2030 targets. A member survey on WHO targets was conducted, with leadership from ILEP. Resource mobilization and partnership: Proposals submitted or nearing completion to MacArthur, Canadian Grand Challenges, Audacious Fund. Relationships being built with key potential donors. Joint session on NTD partnerships jointly undertaken 3 other NTD groups during NNN. A strategic planning session led to the development and approval of a 10-year aligned strategy for the partnership. MDP approved 408.6 million treatments including 348.2 treatments in countries where Lymphatic Filariasis(LF) and onchocerciasis are co-endemic and 60.4 million treatments in IDA countries in 2019. This record-breaking number resulted was celebrated in Haarlem in December as one billion tablets were manufactured by MSD in 2019. In 2019, 117 million tablets were "recovered" from the supply chain due to the close monitoring of applications and interaction with the country program managers. To celebrate achievements and to increase visibility of Merck's global contribution to LF and onchocerciasis elimination, MDP launched the LF elimination award in Togo, which was given to the minister of health during a celebration in Lomé. Following the celebration, MDP received a letter of gratitude from the president of Togo. MDP also coordinated a joint Merck/GSK/MDP press release congratulating Yemen on achieving LF elimination, which was validated by WHO in 2019. 4374455 1634303 13792009 In fiscal year 2019, The Center for Vaccine Equity sector made substantial progress in existing program areas, and expanded its role in current programs. The Center expanded its work into the area of vaccine safety monitoring with the addition of the Brighton Collaboration Program. Polio Eradication Support: In 2019 the Center established an emergency outbreak response team to support the Centers for Disease Control and Prevention (CDC) and other GPEI partners in high-priority surveillance and outbreak response activities around the globe. Serving as the secretariat for the US Polio National Certification Committee, CVE convened a meeting of the committee and submitted a report on the status of US containment to the Regional Certification Committee. Serving as the secretariat for and led by the Center Director, The Polio Antiviral Initiative (PAI) working with ViroDefense, Inc., advanced the development of two antiviral agents (V-7404 and pocapavir) working by different mechanisms of action. A Phase 1 clinical study of V-7404 showed that the highest intended dose was well tolerated and achieved the expected exposures. Pocapavir was administered on a compassionate use basis to treat immune deficient individuals who were excreting poliovirus for prolonged periods. Influenza: To date the Partnership for Influenza Vaccine Introduction delivered/committed to deliver more than 3.6 million doses of influenza vaccine to high-risk groups in partner countries. Five PIVI partner countries are on track to transition to being fully supported by their national government. In the current year the Partnership led creation of a new global alliance of stakeholders, including WHO, GAVI, UNICEF, vaccine manufacturers and others, to support expansion of seasonal vaccination programs worldwide and pandemic vaccine preparedness. The Global Funders Consortium for Universal Influenza Vaccine Development established a platform to track and provide accurate information about next generation influenza vaccines. The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota collaborated with the Unifluvac Working Group in compiling and curating an open-access database of universal influenza vaccine candidates and technologies currently in development. Hepatitis: On World Hepatitis Day 2019 (July 28), the Task Force launched the Coalition for Global Hepatitis Elimination, a collaboration of public and private partners to forge consensus on elimination goals, share knowledge and experience, provide technical assistance, generate new knowledge, and advocate for the elimination of hepatitis B and C. The Coalition supports the global goal to prevent over 7 million deaths by 2030. Coalition work is focused in 5 strategic axes: development of a trusted dynamic evidence base, HEPEXPERT, to guide program development; supporting hepatitis programs to overcome barriers in implementation and evaluation; conducting operational research to improve program effectiveness; and supporting global advocacy and community mobilization. Vaccine Safety: In 2019 the Brighton Collaboration, a scientific association of vaccine safety experts, joined the Task Force. The Brighton Collaboration brings together committed stakeholders, protects scientific independence, facilitates knowledge transfer across different sectors, locations and professions and supports vaccine safety experts. The Collaboration received funding from the Coalition for Epidemic Preparedness Innovation (CEPI) to support their portfolio of vaccine candidates with harmonized safety assessment through development of standards and evaluation tools and provision of safety monitoring and guidance for developers. 0 0 0 42021964 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 1 0 1 1 1 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 124 0 0 175 1 1 1 1 CO ET GT 0 0 0 0 0 0 0 0 0 0 X 11 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 GA X X Daniel N Martins 4046875620 325 Swanton Way Decatur GA 300303001 Teri Plummer McClure Board Chair 1 0 X 0 0 0 James W Curran Board Member 1 0 X 0 0 0 Paula Lawton Bevington Board Member 1 0 X 0 0 0 Mary Ann Peters Board Member 1 0 X 0 0 0 Charles H McTier Board Member 1 0 X 0 0 0 Kent Alexander Board Member 1 0 X 0 0 0 James Jackson Board Member 1 0 X 0 0 0 Deborah Kilpatrick Board Member 1 0 X 0 0 0 Wonya Lucas Board Member 1 0 X 0 0 0 Walter Orenstein Board Member 1 0 X 0 0 0 David A Ross President and CEO 39 1 X X 358432 0 48849 William P Nichols Chief Operating Officer 39 1 X 281378 0 23110 Mark McKinlay Program Director 39 1 X 247623 0 48469 Heather Brooks Director of Organizational Effectiveness 39 1 X 167478 0 39939 Ellen Wild Director of Business Strategy 40 0 X 166115 0 15887 Daniel Martins Chief Financial Officer 39 1 X 140301 0 53410 Patrick O'Carroll Program Sector Head 40 0 X 259370 0 24882 Dionisio Jose Herrera Guibert Program Director 40 0 X 289723 0 57914 Eric Ottesen Program Director 40 0 X 262146 0 20813 Patrick Lammie Sr. Public Health Scientist 40 0 X 210346 0 19871 Paul Emerson Program Director 40 0 X 216311 0 61397 Vivian Singleton Program Director 40 0 X 205848 0 43200 Martha Rogers Program Director 40 0 X 247107 0 22224 Rubina Imtiaz Program Director 40 0 X 227173 0 21474 David G Addis Program Director 40 0 X 215753 0 44701 Yao Sodahlon Program Director 40 1 X 212514 0 55854 Timothy Morris Chief Information Officer - CHAMPS 40 0 X 205447 0 54132 3913065 0 656126 44 0 1 0 Freese Johnson Construction Company 1355 Terrell Mill Rd Bldg 1470 Suite 100 Marietta GA 30067 Building Construction Company 2158650 ViroDefense Inc 5425 Wisconsin Avenue Suite 600 Chevy Chase MD 20815 Antiviral research and development consulting 4200000 Deloitte Consulting LLP 4022 Sells Drive Hermitage TN 37076 Consulting services 866301 HLN Consulting 72810 Hedgehog St Palm Desert CA 92260 Informatic services 511359 Office Creations Inc 5250 Brook Hollow Parkway Norcross GA 30071 Manufactures office furniture 547641 19 0 0 750200 0 23666433 29724416 0 54141049 0 845317 845317 0 0 0 0 0 0 0 0 0 0 640035 0 1222510 0 -582475 0 -582475 -582475 0 0 0 0 750200 750200 221875 528325 0 528325 0 54932216 262842 0 528325 0 0 0 0 2625131 2625131 0 0 4620733 3173702 1447031 0 0 0 0 0 11198049 8393222 2680058 124769 835597 626301 199986 9310 1652717 1153878 481598 17241 813223 606192 198295 8736 15688030 15264734 380563 42733 36769 5471 31298 0 103438 51065 52373 0 0 0 0 0 0 0 49190 17655 31535 0 0 0 0 0 175779 153199 21654 926 1268403 1121108 147247 48 946496 396296 545200 5000 0 0 0 0 728023 95115 632908 0 5012826 4866978 145848 0 0 0 0 0 2158374 1868464 276935 12975 300189 0 300189 0 0 0 0 0 1427769 0 1427769 0 178391 49027 129364 0 Bank Charges 74228 72958 1134 136 Dues and Subscriptions 88214 37522 50692 0 Miscellaneous 41259 30739 10520 0 Other Direct Program Expenses 1418570 1413207 5363 0 415698 0 415698 0 51857096 42021964 9613258 221874 0 0 31964714 23052659 2441658 6616340 0 0 0 0 0 0 0 0 0 847998 627134 31609812 5305813 26734529 26303999 0 9680571 0 0 0 0 0 0 0 0 61988899 66280703 2472336 3073697 0 0 412321 0 6475000 6125000 0 0 0 0 0 0 0 0 2178294 3555938 11537951 12754635 X 26910932 25124158 23540016 28401910 0 0 50450948 53526068 61988899 66280703 3075120 0 0 0 0 0 X 0 1 X 1 1 1 X 35776510 42374053 68115208 36813330 47166232 230245333 0 0 0 0 0 0 0 0 0 0 0 0 35776510 42374053 68115208 36813330 47166232 230245333 46724772 183520561 4472 8370 89763 825669 1189041 2117315 0 0 0 -222353 -598040 -820393 0 0 0 0 0 0 231542255 0 0.79260 0.99564 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2135100 0 2135100 26211582 0 3389576 22822006 0 0 0 0 1456619 0 944295 512324 1806511 0 971942 834569 26303999 0 Interest Rate Swap Liability 415698 Accrued Absences 350786 Payroll Liabilities 1501779 Other Accrued Liabilities 1287675 3555938 54932216 0 0 0 0 0 54932216 0 0 0 54932216 51857096 0 0 0 0 0 51857096 0 0 0 51857096 1 East Asia and the Pacific 0 0 Program Services Support for Trachoma and vaccine projects/services. Papua New Guinea's PK study and Co-administration for trachoma elimination program. Mongolia study of adverse events and birth outcomes among pregnant women receiving influenza vaccine; educational campaign among healthcare workers. Influenza vaccine donation to Laos, Mongolia, and Vietnam and Vaccination Campaign in (4) selected Provinces in Vietnam. 847090 Middle East and North Africa 0 0 Program Services Grant for a global Trachoma/NTD elimination partners conference conducted in Tunisia. 629129 Russia and the newly independent States 0 0 Program Services Health care worker training related to influenza and surveillance in Moldova, Kyrgyzstan to improve influenza surveillance. Influenza vaccine purchase and distribution to Kyrgyzstan, Armenia and Moldova. 539521 Europe (including Iceland and Greenland) 0 0 Program Services Grant to SECID for conducting training in Bulgaria and support health care worker survey and training related to influenza immunization campaign in Albaina and Macedonia. 250814 Sub-Saharan Africa 2 12 Program Services Trachoma elimination SAFE program in Ethiopia and Cameroon, support for MDA scaleup and/or research in Ghana, DRC, Nigeria, S.Sudan and mapping in Nigeria, support for lab construction Cameroon and Pilot study of STH and pregnancy survey in Tanzania. 218654 South Asia 0 0 Program Services Technical support to Ministry of Health Bangladesh for program monitoring surveys and vaccine coverage reporting system, training on skill and capacity on influenza vaccine-Bhutan 139924 2 12 2625132 East Asia and the Pacific Papua New Guinea's PK study and Co-administration for trachoma elimination program. Mongolia study of adverse events and birth outcomes among pregnant women receiving influenza vaccine; educational campaign among healthcare workers. Influenza vaccine donation to Laos, Mongolia, and Vietnam and Vaccination Campaign in (4) selected Provinces in Vietnam. 847090 Wire Transfer 0 None N/A Middle East and North Africa Implementation of a global trachoma/NTD elimination partners conference in Tunisia and knowledge, attitudes and practices of High risk groups(PW),(HCW) regarding influenza vaccine uptake in Tunisia 629129 Wire Transfer 0 None N/A Russia and the newly independent States Health care worker training related to influenza and surveillance in Moldova, Kyrgyzstan to improve influenza surveillance. Influenza vaccine purchase and distribution to Kyrgyzstan, Armenia and Moldova. 539521 Wire Transfer 0 None N/A Europe (including Iceland and Greenland) Grant to SECID for conducting training in Bulgaria and support health care worker survey and training related to influenza immunization campaign in Albaina and Macedonia. 250814 Wire Transfer 0 None N/A Sub-Saharan Africa Trachoma elimination SAFE program in Ethiopia and Cameroon, support for MDA scaleup and/or research in Ghana, DRC, Nigeria, S.Sudan and mapping in Nigeria, support for lab construction Cameroon and Pilot study of STH and pregnancy survey in Tanzania. 218654 Wire Transfer 0 None N/A South Asia Technical support to Ministry of Health Bangladesh for program monitoring surveys and vaccine coverage reporting system, training on skill and capacity on influenza vaccine-Bhutan 139924 Wire Transfer 0 None N/A 21 0 0 0 0 0 0 0 Schedule F, Part I, Line 2 A contract is executed with all the required deliverables and budget. Based on work performance, an agreed percentage of the grant is paid to the recipient after receiving an invoice and a narrative report. Occasionally, there are visits to the countries for feedback and to assess the impact of the project. Budget over-runs have to be explained before a contract amendment, if necessary, is made. Capital Campaign 750200 0 750200 0 0 0 0 0 221875 0 0 750200 0 750200 0 0 0 0 0 221875 221875 528325 X 0 0 0 0 0 0 0 0 0 Teri Plummer McClure Board Chair 0 0 0 0 0 0 0 0 0 0 0 0 0 0 James W Curran Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Paula Lawton Bevington Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Mary Ann Peters Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Charles H McTier Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Kent Alexander Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 James Jackson Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Deborah Kilpatrick Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Wonya Lucas Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Walter Orenstein Board Member 0 0 0 0 0 0 0 0 0 0 0 0 0 0 David A Ross President and CEO 358432 0 0 0 0 0 22851 0 25998 0 407281 0 0 0 William P Nichols Chief Operating Officer 245214 0 36164 0 0 0 22060 0 1050 0 304488 0 0 0 Mark McKinlay Program Director 247623 0 0 0 0 0 22682 0 25787 0 296092 0 0 0 Heather Brooks Director of Organizational Effectiveness 167478 0 0 0 0 0 15353 0 24586 0 207417 0 0 0 Ellen Wild Director of Business Strategy 166115 0 0 0 0 0 15006 0 881 0 182002 0 0 0 Daniel Martins Chief Financial Officer 134501 0 5800 0 0 0 12779 0 40632 0 193712 0 0 0 Patrick O'Carroll Program Sector Head 259370 0 0 0 0 0 23442 0 1439 0 284251 0 0 0 Dionisio Jose Herrera Guibert Program Director 254495 0 35228 0 0 0 22904 0 35010 0 347637 0 0 0 Eric Ottesen Program Director 262146 0 0 0 0 0 19493 0 1320 0 282959 0 0 0 Patrick Lammie Sr. Public Health Scientist 210346 0 0 0 0 0 18922 0 949 0 230217 0 0 0 Paul Emerson Program Director 216311 0 0 0 0 0 20380 0 41018 0 277709 0 0 0 Vivian Singleton Program Director 203977 0 0 0 1871 0 16534 0 26667 0 249049 0 0 0 Martha Rogers Program Director 247107 0 0 0 0 0 21008 0 1217 0 269332 0 0 0 Rubina Imtiaz Program Director 227173 0 0 0 0 0 20453 0 1021 0 248647 0 0 0 David G Addis Program Director 215753 0 0 0 0 0 19226 0 25474 0 260453 0 0 0 Yao Sodahlon Program Director 212514 0 0 0 0 0 19664 0 36190 0 268368 0 0 0 Timothy Morris Chief Information Officer - PHII/CHAMPS 205447 0 0 0 0 0 17843 0 36289 0 259579 0 0 0 A Development Authority of DeKalb County 581500666 000000000 2016-12-15 7000000 Finance the purchase of a building 0 0 0 A 875000 0 7000000 0 0 0 0 0 0 7000000 0 0 2018 0 0 1 1 A 0 0 0 0 0 0 0 1 0 0 A 0 0 0 0 1 1 Truist Bank (formerly Sun Trust Bank) 16.9 0 1 0 0 0 Form 990, Part VI, Section B, Line 11b Once the Return is prepared by the CFO, it is reviewed by management and thereafter made available to all board members for comments, clarifications and corrections. After the board's review, the Return is finalized and filed with the IRS Form 990, Part VI, Section B, Line 12c Board members, officers, and all employees are required to annually sign a declaration that they have read, and have complied with, the Conflict of Interest Policy. Any suspected or reported violations of the policy are to be referred to the Chief Operating Officer who would follow-up and investigate the matter. Form 990, Part VI, Section B, Line 15 The Task Force for Global Health, Inc. is an affiliate of Emory University and as such, all its employees are in fact Emory employees. For both the President and Chief Operating Officer, Emory includes these positions in its annual market review of compensated professionals in these categories. In addition, performance is measured against SMART goals. Furthermore the board reviews performance including a 360 feedback loop finalizing the President's performance. Form 990, Part VI, Section C, Line 19 Three years of audited financial statements and 990 Tax Returns are posted on the organization's website together with the Conflict of Interest policy and governing documents - Bylaws Global Health Solutions Inc 325 Swanton Way Decatur GA 30030 203674498 Provide programmatic support to The Task Force for Global Health, Inc. GA 501 (c)(3) 509(a)(3) Type 1 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0